Press Releases

The Biotechnology Industry Organization (BIO) and BioFlorida commend the Florida Senate Committee on Health Policy for passage of Senate Bill 732 out of committee.

In statehouses around the country, lawmakers are beginning to address the complexities of cutting-edge biotech drugs and the regulatory issues related to the interchangeability of biosimilar medicines.

The BIO Alliance Zone and Translational Research Forum to be featured at the global event for biotechnology.

WASHINGTON, D.C. (March 8, 2013) – Whole Foods announced today that it will require the makers of food products sold in its stores to state on the label if a product contains an ingredient produced through agricultural biotechnology.

BIO and ASTA are pleased to announce that the American Farm Bureau Federation, American Soybean Association , and the National Corn Growers Association have become signatories to the Accord.

Forbes 30 Under 30: The Rising Stars Transforming Science and Healthcare – The Real Future of Biotech.

Global biofuel and renewable chemical company executives and managers developing strategies to further commercialization will speak in breakout sessions at BIO’s 10th annual World Congress on Industrial Biotechnology this June in Montreal, Canada. 

On March 4, 2013, the U.S. House of Representatives passed PAHPRA by a vote of 370-28.

The 2013 BIO International Convention will feature six diverse Super Sessions highlighting pressing industry topics such as the state of the industry, emerging R&D initiatives between public and private sectors,the future of biotechnology under the Affordable Care Act (ACA) and the future of deal-making and global innovation.

BIO lauds the Senate for passing H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), yesterday by a unanimous vote.

Forum to highlight new therapies and diagnosis for rare diseases, business models and partnering strategies for orphan drug products and commercialization of biologics for orphan indications and rare diseases

The U.S. Environmental Protection Agency issued long-awaited approval for advanced and cellulosic biofuels from camelina and energy cane, as well as renewable gasoline from previously approved biomass sources.

The Biotechnology Industry Organization (BIO) announced its plenary session program for the 2013 World Congress on Industrial Biotechnology featuring biofuel and biobased product company executives, scientists and government officials from across the globe. 

The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420 million acres. 

The U.S. Food and Drug Administration (FDA) announced today that it is extending for 60 days the comment period for the genetically engineered AquAdvantage Salmon.

With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities within emerging markets and strategies for growing the global biotech industry

An inside look at two cases facing the Supreme Court of the United States: Bowman v. Monsanto and Molecular Pathology v. Myriad Genetics

 Contrary to the assertions of the oil refiners, advanced biofuels are now a reality, BIO President & CEO Jim Greenwood said today in remarks on the Renewable Fuel Standard at ACORE’s National Renewable Energy Policy Forum, held on Capitol Hill.

BIO announced that it is accepting nominations for the annual George Washington Carver Award to recognize significant contributions by an individual in the field of industrial biotechnology. 

BIO announced the plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 15th Annual BIO CEO & Investor Conference.

2013 is a pivotal year for cellulosic and advanced biofuels. The Renewable Fuel Standard must remain stable, because it ensures that if producers can generate the beneficial fuels, the U.S. fuel market will be open to them.

Hot topics include clinical trials modernization, food security, demonstrating economic value, accessing early-stage innovation, venture philanthropy